The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma

This publication has 42 references indexed in Scilit:

• Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma
  Cancer, 2001
• Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients
  Lung Cancer, 2001
• Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer
  European Journal Of Cancer, 2001
• Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients
  Cancer, 2000
• Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study
  Lung Cancer, 2000
• Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin
  Cancer, 1999
• Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: an overview
  Anti-Cancer Drugs, 1995
• Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype
  European Journal Of Cancer, 1995
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989